Bharat Biotech Unveils India's First Integrated Cell & Gene Therapy Facility in Hyderabad, 2025

Bharat Biotech has proudly launched India's pioneering Cell & Gene Therapy (CGT) center in Hyderabad. This 50,000-square-foot state-of-the-art facility focuses on advancing regenerative and personalized medicine. It aims to tackle significant scientific challenges, including how to achieve precise gene expression, modulate the immune system effectively, and maintain cell survival over long periods. This facility represents a significant step forward in medical science and innovation.

The company has devoted an impressive $75 million to this groundbreaking venture. They're venturing beyond vaccine development and stepping into the realm of advanced regenerative medicine. This modern facility is capable of producing high-titer viral vectors such as AAV, Lentivirus, and Adenovirus. These vectors are essential tools in the world of cell and gene therapy, playing a crucial role in creating treatments for cancer and various genetic disorders.

This is a major milestone in India's biotech and healthcare innovation journey. It offers a bright ray of hope to millions of people in need of advanced medical solutions.

✔ Purpose & Focus:

The facility's goal is to enhance regenerative and personalized therapies.

It tackles challenges like targeted gene expression, immune system adjustment, and ensuring long-term cell viability.

✔  Investment and New Horizons:

Financial Investment: The company has committed $75 million to this initiative.

✔  Cell and Gene Therapy (CGT)research:

Strengthen immune responses to combat cancer.

Develop treatments for genetic blood disorders, including hemophilia.

Ensure the safety of therapeutic proteins in genetic disease treatments.

✔   Facility Details:

A state-of-the-art 50,000 square-foot CGT facility will deliver life-saving treatments for global health needs.

Focuses on conditions like blood cancers and genetic blood disorders.

✔  Expert Leadership:

The initiative is led by Dr. Krishna Ella (Executive Chairman)and Dr. Raches Ella (Chief Development Officer).

Their goal is to make gene therapy more affordable and accessible to all.

✔  Key Innovations:

Advanced Viral Vector Production:

Produces critical viral vectors like AAV, Lentivirus, and Adenovirus for gene therapy.

✔  CAR-T Cell Therapy:

Conducts pioneering research on CD19 CAR T-cell therapy for treating blood cancers.

✔  AI-Powered Cell Therapy:

Collaborates with Prof. Krishanu Saha from the University of Wisconsin, Madison.

Develops innovative CAR cell therapies using AI technology.

✔  Global Impact:

Bharat Biotech is known for producing affordable vaccines, with over 9 billion doses delivered worldwide. The company aims to expand into personalized medicine through global partnerships. This expansion reinforces its commitment to accessible healthcare in India and internationally.

💬Inspired? Let’s talk. Drop your thoughts in the comments—I’d love to hear your take.